Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amplification loop cascade for increasing caspase activity induced by docetaxel.

Dongxu Cao1, Bin Qiao, Zhiqiang Ge

  • 1Department of Pharmaceutical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, Peoples' Republic of China.

Journal of Cellular Biochemistry
|September 9, 2005
PubMed
Summary

Docetaxel induces apoptosis in leukemia cells by creating reactive oxygen species (ROS) and activating caspases. This process involves an amplification loop of ROS and JNK/SAPK activation, ultimately promoting programmed cell death.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Random access elevates DNA from a storage medium to a storage system.

Trends in biotechnology·2026
Same author

A risk-based post ablation follow-up strategy for hepatocellular carcinoma.

JHEP reports : innovation in hepatology·2026
Same author

RHEBL1 expression is activated by the Oct4-Sox2 complex in oral squamous cell carcinoma.

Functional & integrative genomics·2026
Same author

High-Coordination Single-Atom Nanozyme-Based Colorimetric-Photothermal Sensing Platform for Evaluation of Total Antioxidant Capacity.

Analytical chemistry·2026
Same author

Random Attention Mechanism for Deep Quality Modeling and Online Prediction in Chemical Processes.

ACS omega·2026
Same author

Evolution Pathway from Iron Precursors to Fe-N<sub>4</sub> Single-Atom Catalysts via High-Temperature Cyanide Coordination Chemistry.

Journal of the American Chemical Society·2026

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Docetaxel is a microtubule inhibitor used in cancer therapy.
  • Apoptosis, or programmed cell death, is a critical process in cancer treatment.
  • Understanding the molecular events leading to docetaxel-induced apoptosis is crucial for optimizing therapy.

Purpose of the Study:

  • To elucidate the sequence of molecular events triggered by docetaxel in HL-60 human leukemia cells.
  • To investigate the role of reactive oxygen species (ROS) and specific signaling pathways in docetaxel-induced apoptosis.

Main Methods:

  • Treatment of HL-60 cells with docetaxel.
  • Measurement of reactive oxygen species (ROS) production using diphenylene iodonium (DPI).
  • Assessment of caspase-3 activation, JNK/SAPK activation, and bcl-2 phosphorylation using specific inhibitors and genetic manipulation.

Related Experiment Videos

Main Results:

  • Docetaxel induced ROS production via NADPH oxidase, caspase-3 activation, JNK/SAPK activation, and bcl-2 phosphorylation, leading to apoptosis.
  • ROS mediated caspase-3 activation and apoptosis.
  • Caspase inhibition affected JNK/SAPK activation and bcl-2 phosphorylation.
  • JNK/SAPK pathway activation was essential for bcl-2 phosphorylation.
  • Bcl-2 overexpression partially inhibited docetaxel-induced ROS production and apoptosis.

Conclusions:

  • Docetaxel-induced apoptosis involves a sequential cascade including ROS production, caspase activation, JNK/SAPK activation, and bcl-2 phosphorylation.
  • These events form an amplification loop that enhances caspase activity and promotes apoptosis.
  • Targeting this pathway could be a strategy for enhancing docetaxel efficacy in leukemia treatment.